Annexon, Inc. (ANNX)
NASDAQ: ANNX · IEX Real-Time Price · USD
2.85
+0.75 (35.71%)
At close:
May 26, 2023, 4:00 PM
2.92
+0.07 (2.46%)
Pre-market:
May 30, 2023, 4:10 AM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $151.29 million as of May 30, 2023. Its market cap has increased by 18.84% in one year.
Market Cap
151.29M
Enterprise Value
-45.40M
1-Year Change
18.84%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $599.60M to $151.29M, a decrease of -74.77%. That is a compound annual growth rate of -38.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 26, 2023 | 151.30M | 35.70% |
May 25, 2023 | 111.50M | -59.37% |
May 24, 2023 | 274.40M | -7.86% |
May 23, 2023 | 297.80M | -5.88% |
May 22, 2023 | 316.40M | 1.02% |
May 19, 2023 | 313.20M | 1.72% |
May 18, 2023 | 307.90M | -8.93% |
May 17, 2023 | 338.10M | 5.46% |
May 16, 2023 | 320.60M | -0.34% |
May 15, 2023 | 321.70M | 11.01% |
May 12, 2023 | 289.80M | -0.75% |
May 11, 2023 | 292.00M | -2.47% |
May 10, 2023 | 299.40M | 2.75% |
May 9, 2023 | 291.40M | 4.56% |
May 8, 2023 | 278.70M | 4.85% |
May 5, 2023 | 265.80M | 1.03% |
May 4, 2023 | 263.10M | 2.77% |
May 3, 2023 | 256.00M | 3.90% |
May 2, 2023 | 246.40M | -10.47% |
May 1, 2023 | 275.20M | 2.72% |
Apr 28, 2023 | 267.90M | -2.30% |
Apr 27, 2023 | 274.20M | 1.52% |
Apr 26, 2023 | 270.10M | -2.03% |
Apr 25, 2023 | 275.70M | -4.04% |
Apr 24, 2023 | 287.30M | 1.41% |
View and export this data all the way back to 2020.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CVRx, Inc. | 274.42M |
UroGen Pharma Ltd. | 233.83M |
So-Young International Inc. | 224.49M |
Jasper Therapeutics, Inc. | 176.52M |
ChromaDex Corporation | 107.20M |
Werewolf Therapeutics, Inc. | 101.14M |
Checkpoint Therapeutics, Inc. | 42.08M |
BrainsWay Ltd. | 25.14M |
MedAvail Holdings, Inc. | 17.96M |